Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale EVP, Research & CSO sold 2,930 shares at $30.00 ($87,900)
  2. 4 Open-market sale EVP, Research & CSO sold 2,340 shares at $27.29 ($63,848)
  3. 4 Exercise or conversion Chief Medical Officer acquired 20,000 shares (option exercise)
  4. 4 Open-market sale EVP, Research & CSO sold 2,340 shares at $26.26 ($61,448)
  5. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $31.44 ($157,209)
  6. 4 Open-market sale Chief Business Officer sold 6,944 shares at $31.27 ($217,153)
  7. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $35.04 ($133,335)
  8. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $35.49 ($443,608)
  9. 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $43.03 ($239,236)
  10. 4/A Derivatives Options or other derivatives
  11. 4/A Derivatives Options or other derivatives
  12. 4/A Derivatives Options or other derivatives
  13. 4/A Derivatives Options or other derivatives
  14. 4/A Derivatives Options or other derivatives
  15. 4/A Derivatives Options or other derivatives
  16. 4/A Derivatives Options or other derivatives
  17. 4/A Derivatives Options or other derivatives
  18. 4/A Derivatives Options or other derivatives
  19. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $41.74 ($521,795)
  20. 4 Open-market sale Chief Business Officer sold 6,945 shares at $34.75 ($241,342)

Page 20 of 25 · 491 filings